key: cord-0877706-s8e9gp9j
authors: Linares-Fernández, Sergio; Moreno, Julien; Lambert, Elise; Mercier-Gouy, Perrine; Vachez, Laetitia; Verrier, Bernard; Exposito, Jean-Yves
title: Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA
date: 2021-10-19
journal: Mol Ther Nucleic Acids
DOI: 10.1016/j.omtn.2021.10.007
sha: d809cafcae47e62700bcfa2420725c0d95b1513c
doc_id: 877706
cord_uid: s8e9gp9j

mRNA is a blooming technology for vaccination and has gained global attention during the SARS-CoV-2 pandemic. However, the recent clinical trials have highlighted increased reactogenicity when using high mRNA doses. Intending to increase the potency of mRNA therapeutics and to decrease the therapeutic dose, we designed a mRNA backbone and optimized the mRNA purification process. We used the eGFP reporter gene flanked by one 5’ and two 3’ UTRs of the human β-globin as a reference mRNA and identified the most promising mRNA sequence using in vitro and in vivo models. First, we assessed the impact of different poly-A sizes on translation and selected the most optimal sequence. Then, we selected the best 5’UTR among synthetic sequences displaying a high ribosome loading. Finally, we evaluated the transfection efficiency of our standard mRNA template after two capping strategies and purification using either dsRNA depletion, dephosphorylation of 5’PPP RNA or both combined. Double purification was shown to give the best results. Altogether, the use of a newly defined 5’UTR coupled to post-transcriptional treatments will be of great interest in the mRNA vaccine field, by limiting the amount of the antigen-coding transcript, and subsequently the formulation components needed for an efficient vaccination.

The use of mRNA as a vaccine candidate is transforming the field of vaccinology and has the 44 potential to initiate a new era on the prevention of infectious diseases. 1 Moreover, increasing the potency of mRNA vaccines is crucial for dose sparing, which will 55 decrease the production cost and increase the number of doses of potential life-saving 56 vaccines, extremely needed in the current and future pandemics. 57

To improve the potency of mRNA vaccines and optimize the mRNA stability, researchers 58 focused early efforts through modifications of the untranslated sequences. Indeed, due to their 59 long half-life and efficient protein production, the use of highly stable untranslated regions 60 (UTRs) from the  and -globin genes from Human or Xenopus laevis improved the mRNA 61 stability. 5,6 Later, the use of two copies of the 3' UTR of β-globin in tandem improved the 62 stability and the translational efficiency of mRNAs. Recent studies provided promising results 63 such as optimizing the 3'UTR region by selecting stable sequences and using two copies in 64 tandem. 7,8 Another strategy to improve mRNA stability was to tailor the poly-A region. 65

Initially, Holtkamp et al. 9 found that 120 adenosines were optimal for translation in human 66 dendritic cells. However, the impact of the poly-A size has been recently re-evaluated, 67 J o u r n a l P r e -p r o o f sequence after transfecting HEK293T cells. With the aim to optimize the translation 143 efficiency of our standard 148-A mRNA, 6 different synthetic 5'UTRs with high ribosome 144 loading and high number of reads were selected from this library. As shown in Figure 1B Figure 4A ). At 24 hours post-transfection, the intensity of expression was significantly more 154 important using UTR4 mRNA than others mRNA (see magnification square in Figure 4A ). 155

When considering the overall fluorescence detected during this time course analysis, the 156 UTR4 mRNA presented significantly higher eGFP expression than other mRNAs ( Figure  157 4B), except the L7601 mRNA. Moreover, the UTR4 mRNA generated 33% more eGFP 158 compared to the standard β-globin 148A mRNA. Interestingly, the high ribosome loading 159 UTR2 and UTR5 showed a low level of eGFP production. Interestingly, among the lowest 160 eGFP-expressing mRNAs, UTR3 and UTR5 presented a significant lower percentage of 161 viability at 24 hours post-transfection (Fig. S2A) . Although the origin of this cell toxicity is 162 unknown, the presence of a common 10 bp near the Kozak sequence on both 50 bp UTRs 163 could participate to this toxicity ( Figure S1 , GTGTCAGTGA). 164

The same analyses were performed using the DC2.4 cells. Fluorescence images of DC2.4 165 cells realized 24 hours post-transfection showed that UTR4 mRNA presented the highest 166 eGFP production ( Figure S5 ). When the eGFP expression was assessed by flow cytometry 167 J o u r n a l P r e -p r o o f ( Figure 5A ), at 24 hours post-transfection, the intensity of expression was significantly more 168 important using UTR4 mRNA than others mRNA. The total amount of fluorescence detected 169 during the time course analysis ( Figure 5B ) confirmed that the UTR4 mRNA resulted in a 170 significantly higher expression compared to other mRNAs. The total eGFP expression in 171 DC2.4, calculated with the AUC (Figure 5B ), was similar to the expression obtained in HeLa 172 cells ( Figure 4B ). Thus, a 37% increase in eGFP expression was obtained with the UTR4 173 mRNA in comparison to 148A-mRNA, illustrating the added value of this specific 5' UTR. 174

Another transfection reagent was used to transfect DC2.4 cells with 148-A and UTR4 175 mRNAs ( Figure S6) with 148-A, UTR2 and UTR4 naked mRNA or mRNA-LNP complexes ( Figure 6C ). This 190 qualitative study indicated a higher eGFP expression with UTR4 than with 148A and UTR2 191 mRNAs and confirmed the results obtained in vitro. Moreover, a better eGFP expression was 192 obtained using mRNA-LNP complexes than with naked mRNA. 193

The adequate production and purification of IVT mRNA can drastically affect the antigen 195 expression. Indeed, a high capping efficiency in the adequate Cap-1 conformation evades host 196 responses by interferon-induced proteins with tetratricopeptide repeats (IFIT) family 197 members, and favors mRNA translation. 23 Moreover, it is also essential to purify the IVT 198 mRNA from the contaminants generated during the reaction. Indeed, those contaminants, 199 such as dsRNA or in a lesser extent 5'PPP uncapped mRNA, activate PRRs and block the 200 cellular protein synthesis. 12 201

Here, the standard 148A-mRNA was produced using either the anti-reverse cap analog 202 (ARCA) or the Vaccinia virus capping enzyme. Then, the IVT mRNAs were depleted of 203 dsRNA by cellulose chromatography, and/or dephosphorylated with antarctic phosphatase. 204

An illustration of the purification strategy and mRNA recovery yields is presented in Figure  205 S7. All these mRNAs were analyzed by agarose gel electrophoresis, and the presence of sharp 206 bands confirmed their overall integrity ( Figure S8A ). 207

After cellulose chromatography, the dsRNA depletion was confirmed by dot blot using the J2 208 anti-dsRNA antibody ( Figure S8B ). Interestingly, the amount of dsRNA depended on the 209 method used for mRNA production, being higher in ARCA than in Vaccinia capping system. 7B, respectively). The results showed that Vaccinia virus capping is more efficient than 220 ARCA capping in both cell lines. As presented in Figure To evaluate the gain of translation of these purification procedures in human primary cells, 232 human moDCs were transfected with the different types of ARCA capped 148A-mRNAs and 233 their eGFP expression quantified by flow cytometry 24 hours after transfection ( Figure 7C ). 234

The results obtained were comparable with those generated with DC2.4 cells but revealed a 235 higher increase of the eGFP expression between the dephosphorylated/dsRNA depleted 236 mRNA and untreated mRNA (three-fold). moDCs being a better tool for analyzing innate 237 immune responses via RNA sensors, 13 IFN- and TNF- productions were analyzed 24 hours 238 post-transfection with ARCA capped 148A-mRNA treated or not with phosphatase and 239 cellulose chromatography ( Figures 7D and 7E ). The lowest IFN- and TNF- amounts were 240 detected in the supernatant of moDCs transfected with dsRNA-depleted mRNA. A 241 phosphatase treatment did not decrease the levels of IFN- and TNF-in comparison to 242 untreated mRNA. Altogether, these results indicate that, at 24 hours post transfection, the 243 dsRNA has an important impact on innate immune response. However, the double treatment 244 of mRNA allows the best eGFP production. 245

The use of mRNA in vaccinology is a revolutionary technology that has exploded in recent Poly-A tail plays an important function in the stability and regulation of translation efficiency 260 of the mRNA. 24 However, due to its instability during bacterial plasmid production, the poly-261 A tail has been limited to 120 units. An alternative strategy has been developed to avoid this 262 instability, and consisted to include an internal 10 nucleotide linker into the poly-A 263 stretch. 25,26 By using highly stable bacteria (NEB stable competent Escherichia coli coli 264 strain), we have been able to propagate and maintain a plasmid containing a 148 A tail, and 265

showed that this mRNA offers the best mRNA translation efficiency into DC2.4. These Hence, only UTR4 mRNA allowed to produce significantly higher level of eGFP than L7601 282 mRNA in DC2.4 cells. Since the untranslated (origin) and translated (codon optimization) 283 sequences of this commercial mRNA are unknown, the discrepancy observed between these 284 two cell lines cannot be discussed. From this study, we showed that the selection of high 285 ribosome loading 5'UTRs sequence is a promising tool to improve mRNA potency, although 286 it is not always correlated with high protein expression. Hence, a low level of eGFP 287 production is obtained with UTR2 and UTR5 mRNAs in both cell lines (Figures 4 and 5) , 288 while UTR2 presented a higher eGFP expression in moDCs ( Figures 6A and 6B ). Therefore, 289

it is important to validate the selected 5'UTR and 3'UTR used for the gene of interest, and the 290 target cell types. Here, we have shown that UTR4 allows a high level of eGFP expression in 291 human and mouse cells, as well as in vivo after intramuscular injection of adult zebrafish. As 292 shown in Figure 6C , incorporation of naked mRNA into zebrafish cells and subsequent GFP 293 expression in the zebrafish tissues was monitored. A comparable result had been previously 294 observed after intramuscular injection of plasmid DNA into adult zebrafish with, and showed 295 the nucleic acid entering the cells (myocytes and antigen-presenting cells) at the site of 296 administration. 28 Other strategies can be used to improve mRNA translation. For example, the 297 depletion of strong secondary structures preventing ribosome scanning within the 5' UTR, a 298 codon optimization of the coding sequences or the reduction of miRNA sites. 299

Apart from the untranslated sequences, other parameters can modulate the translation process 300 such as secondary structures or innate immunity induction. For instance, a successful 301 approach to avoid an overactivation of the innate immunity and increase translation of mRNA 302 is the use of modified nucleosides such as methyl-pseudo uridine. 29 This strategy is the 303 approach followed by the two currently used worldwide SARS-CoV-2 vaccines. However, 304 other factors like the presence of uncapped mRNA and dsRNA are still a source of innate 305 immunity activation. As shown in Figure 7 , a better efficiency is achieved with enzymatic 306 capped mRNA compared to ARCA capped mRNA in the two cell lines used (+67% in HeLa, 307 +45% in DC2.4). This can be due to the difference in capping efficiency (70-80% with ARCA 308 vs 98-100% with vaccinia virus system), the cap conformation (Cap-0 in ARCA vs Cap-1 in 309 vaccinia virus system) and the amount of dsRNA which is more important in mRNA samples 310 produced using the ARCA capping method ( Figure S8B ). It has been shown that dsRNA 311 removal through HPLC or cellulose methods drastically enhances the translational efficiency 312 of IVT mRNAs. 14,30 This dsRNA depletion leads to a decrease of type-I interferon and a were slightly modified to include in the 5' and 3' ends, a HindIII site and a NcoI site that is 365 part of the Kozak sequence, respectively. The synthetic 5' UTR inserts were generated using 366 two complementary primers (Table S1 ). Briefly, an equimolar amount of oligonucleotide 367 pairs was heated for 5 min at 95°C, and then slowly cooled until room temperature to allow 368 their hybridization. The different ds 5' UTR were inserted between the HindIII and NcoI sites 369 of the IVT-148A plasmid, allowing the formation of the IVT-UTR1 to IVT-UTR6 constructs. 370

All plasmids were propagated using NEB stable competent E. coli cells (New England 371

Biolabs (NEB), France) and sequences were checked by Sanger sequencing. The fasta 372 sequences are available ( Figure S1 ). 

To eliminate dsRNA, the IVT-mRNAs were subjected to a cellulose-based purification 389 To increase the potency of mRNA therapeutics and decrease their reactogenicity, we have combined several strategies to optimize mRNA expression in transfected target cells. Our research arrives timely in the field, providing the "know-how" to achieve high potency mRNA, with a 3-fold more efficient mRNA translation into Antigen Presenting Cells. 

Generating the 578 optimal mRNA for therapy: HPLC purification eliminates immune activation and 579 improves translation of nucleoside-modified, protein-encoding mRNA

A Facile Method for the Removal of dsRNA Contaminant 583 from In Vitro-Transcribed mRNA

Synthesis of low 585 immunogenicity RNA with high-temperature in vitro transcription

Suppression of RNA 588 Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the 589 Evolutionary Origin of RNA

Uridine Depletion and Chemical Modification Increase Cas9 mRNA 593 Activity and Reduce Immunogenicity without HPLC Purification

5'-597 triphosphate RNA requires base-paired structures to activate antiviral signaling via 598 RIG-I

The role of poly(A) in the translation and stability of mRNA. 600 Current Opinion in

The Relationship between Eukaryotic 602 Translation and mRNA Stability

Design, Assembly, Production, and Transfection of 604 Synthetic Modified mRNA

Human 5′ UTR design and variant effect prediction from a 607 massively parallel translation assay

Inhibition of translation by IFIT family members is 610 determined by their ability to interact selectively with the 5'-terminal regions of 611 cap0-, cap1-and 5'ppp-mRNAs

Tales of Detailed Poly(A) Tails. 613 Trends in

Elimination of large tumors in mice by 616 mRNA-encoded bispecific antibodies

Segmented poly(A) tails significantly reduce recombination of plasmid DNA 619 without affecting mRNA translation efficiency or half-life

Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 622 5′-UTRs

Immunization of 624

Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Incorporation of Pseudouridine Into mRNA Yields Superior 629 Nonimmunogenic Vector With Increased Translational Capacity and Biological 630 Stability

Generating the 632 optimal mRNA for therapy: HPLC purification eliminates immune activation and 633 improves translation of nucleoside-modified, protein-encoding mRNA

IDENTIFICATION OF A NOVEL CELL 636 TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE

Poly(lactic acid) nanoparticles and cell-penetrating 640 peptide potentiate mRNA-based vaccine expression in dendritic cells triggering 641 their activation

Transparent Adult Zebrafish 645 as a Tool for In Vivo Transplantation Analysis

An analysis of variance test for normality 647 (complete samples)

mRNA (external control), and eGFP mRNA displaying either the 5'UTR of human β-globin 707

UTR (UTR1 to UTR6) were transfected into DC2.4 cells (125ng of mRNA 708 per well). A/ Time course analysis of eGFP expression was performed by flow cytometry

The measurements were acquired at 4, 24, 48, and 96 hours post-transfection, and MFIs 710 normalized with eGFP expression of 148A-mRNA at 24 hours post-transfection. Data were 711 determined as the mean +/-SD of 3 independent experiments with four technical replicates

The relative eGFP expression levels were normalized to that of 148A-714 mRNA assay. Statistical comparisons were only based on the UTR4 mRNA

Figure 6. UTR4 vs UTR2 and 148A-mRNAs expression into moDCs and adult zebrafish

UTR2, UTR4 and 148A-mRNAs were transfected into moDCs (125ng of mRNA per well)

The 720 measurements were acquired at 24, 48, and 96 hours post-transfection, and MFIs normalized 721 with eGFP expression of 148A-mRNA at 24 hours post-transfection. Data were determined as 722 the mean +/-SD of 3 independent experiments with four technical replicates. B/ Total eGFP 723 expression of the different mRNAs was represented by calculating the area under the curve 724 (AUC). The relative eGFP expression levels were

Statistical comparisons were only based on the UTR4 mRNA. Statistical significance was 726 assessed by nested one-way ANOVA

0001. C/ Two or three adult zebrafish were injected intramuscularly with 10 L of naked 728 mRNA (20 ng/L) or 10 L of mRNA-LNP complexes (200 ng of mRNA

eGFP expression observed using a Leica fluorescent stereoscope on anesthetized animals at 730 48 hours post-injection is shown. The site of injection and the location where the picture was 731

taken (red square) is presented in the drawing. Comparable results were obtained at 24 hours 732 post-injection (Data not shown)

ARCA or vaccinia capped 148A-mRNAs 735 were submitted to a dsRNA depletion by cellulose chromatography and/or a phosphatase 736 treatment. These mRNAs were transfected into HeLa (A) or DC2.4 (B) cells, and eGFP 737 expression was monitored 24 hours later by flow cytometry. C/ ARCA capped 148A-mRNAs 738 submitted to a dsRNA depletion by cellulose chromatography and/or a phosphatase treatment 739 were transfected into moDCs

Transfection were realized in 48 well plates, with 125 ng or 250 ng of mRNA for 741

The different types of 148A-mRNAs were transfected into 742 moDCs and the IFN- (D) and TNF- (E) were measured in the supernatant 24 hours later

Control, untransfected cells; Trans-IT, Transit reagent without mRNA; mRNA No-Cap

The relative eGFP 745 expression levels were normalized to that of 148A-mRNA ARCA non-treated. Statistical 746 significance was assessed by nested one-way ANOVA. *, p < 0.05; **